| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/10/2013 | WO2013004856A1 Extracts of hibiscus sabdariffa, lippia citriodora and/or stevia rebaudiana for the treatment and/or prevention of hepatic steatosis and/or inflammatory and metabolic disorders |
| 01/10/2013 | WO2013004669A1 Multivalent oligosaccharides |
| 01/10/2013 | WO2013004171A1 Use of c15-substituted andrographolide derivatives in preparation of anti-hepatitis b virus medicament |
| 01/10/2013 | WO2013004069A1 Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases |
| 01/10/2013 | WO2013004032A1 Composition for treating chicken intestine toxicity syndrome and preparation method thereof |
| 01/10/2013 | WO2012138076A3 Composition containing herbal extract mixture for prevention or treatment of gastrointestinal diseases |
| 01/10/2013 | WO2012069658A8 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders |
| 01/10/2013 | US20130012692 Sodium channel blockers |
| 01/10/2013 | US20130012604 Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease |
| 01/10/2013 | US20130012602 Methods of using znf365 genetic variants to diagnose crohn's disease |
| 01/10/2013 | US20130012592 Agomelatine hydrobromide hydrate and preparation thereof |
| 01/10/2013 | US20130012583 Vinyl substituted fatty acids |
| 01/10/2013 | US20130012575 Plant extract from low-thc cannabis for the treatment of disease |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012545 Amido-Thiophene Compounds and Their Use |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012521 Apoptosis signal-regulating kinase inhibitors |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012510 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1 |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012494 Cyclopropyl-fused-1,3-thiazepines as bace1 and/or bace2 inhibitors |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012472 Composition and methods of inhibiting gastrointestinal pathogen infection |
| 01/10/2013 | US20130012466 Colchicine neoglycosides and methods for their synthesis and use |
| 01/10/2013 | US20130012455 Use of ARC for inhibiting cell death during liver failure |
| 01/10/2013 | US20130012454 Orally Disintegrating Compositions of Linaclotide |
| 01/10/2013 | US20130012444 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012432 Peptides for Treatment of Obesity |
| 01/10/2013 | US20130012427 Polypeptides |
| 01/10/2013 | US20130011502 Composition for a dietary supplement for the treatment of hemorrhoids |
| 01/10/2013 | US20130011501 Anti-Fever Botanical Composition and Uses Thereof |
| 01/10/2013 | US20130011498 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate |
| 01/10/2013 | US20130011482 Dual component medicament delivery system |
| 01/10/2013 | US20130011471 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011464 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 01/10/2013 | US20130011413 Method and Pharmaceutical Composition for Treatment of Intestinal Disease |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011397 Transforming growth factor-beta (TGF-beta) antagonists for use in treating pain |
| 01/10/2013 | US20130011391 Anti-psgl-1 antibodies and uses thereof |
| 01/10/2013 | US20130011384 Use of a Material, Produced from Fungal Fermentation, as a Food Supplement |
| 01/10/2013 | US20130011374 Growth inhibition of microorganisms by lactic acid bacteria |
| 01/10/2013 | US20130011368 Metabolically Active Micro-Organisms and Methods for Their Production |
| 01/10/2013 | US20130011336 Imaging agents of fibrotic diseases |
| 01/10/2013 | CA2840983A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/10/2013 | CA2840924A1 Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases |
| 01/10/2013 | CA2840821A1 Pharmaceutical composition and food composition for preventing and ameliorating motility disorders of gastrointestinal tract |
| 01/09/2013 | EP2543668A1 Pyridopyrazindione derivative and use thereof as an antiulcer agent |
| 01/09/2013 | EP2543388A1 Drug for inflammatory bowel disease |
| 01/09/2013 | EP2542547A2 Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | EP2542528A1 Heterocyclic amides as rock inhibitors |
| 01/09/2013 | CN102869381A Drug for inflammatory bowel disease |
| 01/09/2013 | CN102869366A Prevention and treatment of allergic diarrhoea |
| 01/09/2013 | CN102869359A Imidazopyridine compounds, compositions and methods of use |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863527A Humanized hepatitis b virus resistance surface antigen gene engineering antibodies and preparation method and application thereof |
| 01/09/2013 | CN102863338A Compound and medical use thereof |
| 01/09/2013 | CN102862985A Preparation of hydrolysable calcium potassium phosphosilicate active materials and application thereof |
| 01/09/2013 | CN102861337A Egualen sodium containing solid preparation |
| 01/09/2013 | CN102861319A Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/09/2013 | CN102861317A Application of salmonella flagellin derivative in preparation of medicines for preventing and treating inflammatory bowel diseases |
| 01/09/2013 | CN102861310A Medicine for hepatitis B |
| 01/09/2013 | CN102861306A Group of dark plum fruit combined tablets |
| 01/09/2013 | CN102861305A Medicament for treating acute and chronic colonitis |
| 01/09/2013 | CN102861301A Traditional Chinese medicine formula for treating chronic diarrhea (deficiency-cold in spleen and stomach) |
| 01/09/2013 | CN102861298A Traditional Chinese medicine composition for treating chronic gastritis |
| 01/09/2013 | CN102861297A Traditional Chinese medicine decocted tea or particle tea bag preparation for treating fatty liver |
| 01/09/2013 | CN102861294A Thirteen-ingredient liver therapy capsule |
| 01/09/2013 | CN102861286A Prescription of traditional Chinese medicine for treating esophageal stenosis |
| 01/09/2013 | CN102861282A Prescription of traditional Chinese medicine for treating vomit |
| 01/09/2013 | CN102861266A Traditional Chinese medicine prescription for treating damp-heat dysentery |
| 01/09/2013 | CN102861265A Medicinal tea for treating apocleisis and preparation method and application |
| 01/09/2013 | CN102861261A Chinese medicinal preparation for improving living quality of patient suffering from advanced malignant tumor |
| 01/09/2013 | CN102861257A External-use medicine for treating rectocele and haemorrhoids and preparation method thereof |
| 01/09/2013 | CN102861252A Blood-cooling and heat-removing tablet |
| 01/09/2013 | CN102861247A Traditional Chinese medicine formula for treating hyperemesis gravidarum |
| 01/09/2013 | CN102861242A Chinese medicine composition for preventing and treating dizziness and preparation method thereof |
| 01/09/2013 | CN102861234A Traditional Chinese medicine for enhancing pancreatic functions |
| 01/09/2013 | CN102861233A Drug for treating constipation |
| 01/09/2013 | CN102861230A Application of Chinese medicine composition in preparing medicines for treating organ fibrosis |
| 01/09/2013 | CN102861225A Radix ophiopogonis yin-nourishing and liquid engendering tablets |
| 01/09/2013 | CN102861222A Spina date seed heart-nourishing tablet |
| 01/09/2013 | CN102861219A Traditional Chinese medicine composition for treating oral ulcer |
| 01/09/2013 | CN102861199A Traditional Chinese medicine composition for treating gastroesophageal reflux disease and preparation method |
| 01/09/2013 | CN102861198A Pure traditional Chinese medicine preparation for treating cirrhosis with ascites |
| 01/09/2013 | CN102861194A Liver clearing capsules |
| 01/09/2013 | CN102861178A Traditional Chinese medicine composition for preventing icteric hepatitis of poultry |
| 01/09/2013 | CN102861177A Chinese medicinal composition for nourishing spleen and enriching stomach and preparation method thereof |
| 01/09/2013 | CN102861175A Traditional Chinese medicine for treating tinnitus cerebri of syndrome of marrow depletion due to kidney deficiency |
| 01/09/2013 | CN102861171A Traditional Chinese medicine composite for treating bovine stomatitis and preparation method thereof |
| 01/09/2013 | CN102861170A Traditional Chinese medicine composition for treating frequent micturition |
| 01/09/2013 | CN102861146A Medicine for treating chronic diarrhea |